IL103383A0 - Pharmaceutical compositions containing glutamine and methods for the use thereof - Google Patents
Pharmaceutical compositions containing glutamine and methods for the use thereofInfo
- Publication number
- IL103383A0 IL103383A0 IL103383A IL10338392A IL103383A0 IL 103383 A0 IL103383 A0 IL 103383A0 IL 103383 A IL103383 A IL 103383A IL 10338392 A IL10338392 A IL 10338392A IL 103383 A0 IL103383 A0 IL 103383A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- pharmaceutical compositions
- compositions containing
- containing glutamine
- glutamine
- Prior art date
Links
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 4
- 102000018997 Growth Hormone Human genes 0.000 abstract 3
- 108010051696 Growth Hormone Proteins 0.000 abstract 3
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 3
- 230000002708 enhancing effect Effects 0.000 abstract 3
- 239000000122 growth hormone Substances 0.000 abstract 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77141591A | 1991-10-07 | 1991-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL103383A0 true IL103383A0 (en) | 1993-03-15 |
Family
ID=25091736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103383A IL103383A0 (en) | 1991-10-07 | 1992-10-08 | Pharmaceutical compositions containing glutamine and methods for the use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5288703A (xx) |
| EP (1) | EP0607278B1 (xx) |
| JP (1) | JP3614427B2 (xx) |
| AT (1) | ATE216253T1 (xx) |
| AU (1) | AU661242B2 (xx) |
| CA (1) | CA2120626C (xx) |
| DE (1) | DE69232561T2 (xx) |
| DK (1) | DK0607278T3 (xx) |
| ES (1) | ES2174838T3 (xx) |
| IL (1) | IL103383A0 (xx) |
| WO (1) | WO1993006839A1 (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0776213A1 (en) * | 1994-09-21 | 1997-06-04 | Pharmacia & Upjohn Aktiebolag | Method of treating hypertension in pregnant mammals |
| GB9609993D0 (en) * | 1996-05-14 | 1996-07-17 | Norbrook Lab Ltd | Oral rehydration product |
| GB2329336B (en) * | 1996-05-14 | 1999-11-10 | Norbrook Lab Ltd | Oral rehydration product comprising glutamine |
| US5952301A (en) * | 1996-12-10 | 1999-09-14 | 1149336 Ontario Inc. | Compositions and methods for enhancing intestinal function |
| US5981590A (en) * | 1997-03-17 | 1999-11-09 | Probiotix, Inc. | Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage |
| US6051557A (en) * | 1997-05-16 | 2000-04-18 | 1149336 Ontario Inc. | Methods of enhancing functioning of the upper gastrointestinal tract |
| US20040248788A1 (en) * | 2001-07-06 | 2004-12-09 | Vickers Mark Hedley | Hypertenson treatment |
| US20030099722A1 (en) * | 2001-10-09 | 2003-05-29 | Baxter Jeffrey H. | Methods and compositions for providing glutamine |
| WO2004001020A2 (en) | 2002-06-19 | 2003-12-31 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Methods and means to promote gut absorption |
| US7323206B1 (en) | 2003-03-04 | 2008-01-29 | B. Braun Medical Inc. | Reagents and methods for all-in-one total parenteral nutrition for neonates and infants |
| ES2389805T3 (es) * | 2003-09-12 | 2012-10-31 | University Of Colorado | Glutamina para su uso en el tratamiento de una lesión |
| PL370937A1 (pl) * | 2004-10-29 | 2006-05-02 | Sgp & Sons Ab | Preparat żywieniowy i/lub farmaceutyczny do stosowania w profilaktyce i leczeniu niedoborów wchłaniania mikroelementów z przewodu pokarmowego oraz zastosowanie preparatu farmaceutycznego jako czynnika stymulującego wchłanianie mikroelementów z przewodu pokarmowego do krwi |
| US8748126B2 (en) | 2005-11-29 | 2014-06-10 | Actogenix N.V. | Induction of mucosal tolerance to antigens |
| ES2492468T3 (es) | 2007-01-25 | 2014-09-09 | Actogenix N.V. | Tratamiento de enfermedad inmunitaria por administración a través de la mucosa de antígenos usando Lactobacillus genéticamente modificado |
| WO2018079573A1 (ja) * | 2016-10-26 | 2018-05-03 | 味の素株式会社 | 消化管における吸収低下の改善用組成物、および消化管における吸収の促進用組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0235205B1 (en) * | 1985-08-22 | 1992-10-28 | Gropep Pty. Ltd. | Peptide analogues of mammalian insulin-like growth factor-1 |
| US4857555A (en) * | 1985-09-12 | 1989-08-15 | Brigham & Women's Hospital | Method of treating catabolic dysfunction |
| US4863901A (en) * | 1986-01-09 | 1989-09-05 | Brigham & Women's Hospital | Use of growth hormone for nitrogen retention under hypocaloric conditions |
| US4876242A (en) * | 1987-09-21 | 1989-10-24 | Merck & Co., Inc. | Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
| DE3852636T2 (de) * | 1987-12-24 | 1995-05-04 | Gropep Pty Ltd | Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2). |
| US5122512A (en) * | 1988-09-12 | 1992-06-16 | Pitman-Moore, Inc. | Swine growth promoting composition |
| SE9002732D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product containing growth factor |
-
1992
- 1992-10-07 US US07/957,174 patent/US5288703A/en not_active Expired - Lifetime
- 1992-10-07 JP JP50710393A patent/JP3614427B2/ja not_active Expired - Lifetime
- 1992-10-07 WO PCT/US1992/008445 patent/WO1993006839A1/en active IP Right Grant
- 1992-10-07 DK DK92921577T patent/DK0607278T3/da active
- 1992-10-07 AU AU27906/92A patent/AU661242B2/en not_active Expired
- 1992-10-07 DE DE69232561T patent/DE69232561T2/de not_active Expired - Lifetime
- 1992-10-07 ES ES92921577T patent/ES2174838T3/es not_active Expired - Lifetime
- 1992-10-07 AT AT92921577T patent/ATE216253T1/de active
- 1992-10-07 EP EP92921577A patent/EP0607278B1/en not_active Expired - Lifetime
- 1992-10-07 CA CA002120626A patent/CA2120626C/en not_active Expired - Lifetime
- 1992-10-08 IL IL103383A patent/IL103383A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2120626A1 (en) | 1993-04-15 |
| DK0607278T3 (da) | 2002-06-17 |
| US5288703A (en) | 1994-02-22 |
| DE69232561T2 (de) | 2002-11-28 |
| AU2790692A (en) | 1993-05-03 |
| JPH07501796A (ja) | 1995-02-23 |
| WO1993006839A1 (en) | 1993-04-15 |
| ATE216253T1 (de) | 2002-05-15 |
| EP0607278A4 (en) | 1995-03-29 |
| DE69232561D1 (de) | 2002-05-23 |
| AU661242B2 (en) | 1995-07-13 |
| JP3614427B2 (ja) | 2005-01-26 |
| EP0607278A1 (en) | 1994-07-27 |
| EP0607278B1 (en) | 2002-04-17 |
| CA2120626C (en) | 2009-10-06 |
| ES2174838T3 (es) | 2002-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL103383A0 (en) | Pharmaceutical compositions containing glutamine and methods for the use thereof | |
| NO931766D0 (no) | Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin | |
| HUT68525A (en) | Pharmaceutical compositions of prolonged delivery, containing peptides | |
| EP0274431A3 (en) | Drug delivery compositions and methods | |
| EP0647133A4 (en) | COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY. | |
| DE69008476D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose. | |
| EP0592569A4 (en) | COMPOSITION AND METHOD FOR TRANSDERMAL ADMINISTRATION OF DICLOFENAC. | |
| EP0306824A3 (en) | Stabilized human protein preparations | |
| HUT64838A (en) | Method for preparing medical preparative with tramadole content | |
| HUT56583A (en) | Process for producing peptide derivatives and pharmaceutical and diagnostic compositions comprising such compounds | |
| RU93043625A (ru) | Композиция, включающая вещество трамадол и ацетаминофен, и способ лечения с ее использованием | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| EP0816413A3 (en) | Purified polylactide and pharmaceutical composition thereof | |
| RU93053497A (ru) | Новые пептиды-агонисты и их использование | |
| HUT59833A (en) | Process for producing pharmaceutical compositions containing calcitoninogene like peptides for treating erectional disfunctions | |
| SG48724A1 (en) | Cosmetic and/or pharmaceutical compositions and methods for their use | |
| GR3025792T3 (en) | Use of phosphonates for the treatment of osteoporosis. | |
| NZ236614A (en) | Therapeutic composition containing corticosteroid and igf-i, the igf-i reducing or preventing the adverse effects of the corticosteroid | |
| AU5548894A (en) | An intravenous solution that diminishes body protein loss | |
| EP0683668A4 (en) | PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION. | |
| AU1432292A (en) | Drug delivery composition and method of using the same | |
| ATE157010T1 (de) | Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen | |
| HUT63575A (en) | Stabilized pharmaceutical composition comprising the reduced form of non-glycosylated, recombinant human interleukin-2 | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 |